These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 35343796

  • 21. Bifidobacterium animalis subsp. lactis LPL-RH improves postoperative gastrointestinal symptoms and nutrition indexes by regulating the gut microbiota in patients with valvular heart disease: a randomized controlled trial.
    Lan W, Yang H, Zhong Z, Luo C, Huang Q, Liu W, Yang J, Xiang H, Tang Y, Chen T.
    Food Funct; 2024 Jul 15; 15(14):7605-7618. PubMed ID: 38938120
    [Abstract] [Full Text] [Related]

  • 22. Bifidobacterium animalis subsp. lactis Probio-M8 undergoes host adaptive evolution by glcU mutation and translocates to the infant's gut via oral-/entero-mammary routes through lactation.
    Zhong Z, Tang H, Shen T, Ma X, Zhao F, Kwok LY, Sun Z, Bilige M, Zhang H.
    Microbiome; 2022 Nov 22; 10(1):197. PubMed ID: 36419187
    [Abstract] [Full Text] [Related]

  • 23. Lacticaseibacillus rhamnosus Probio-M9-Driven Mouse Mammary Tumor-Inhibitory Effect Is Accompanied by Modulation of Host Gut Microbiota, Immunity, and Serum Metabolome.
    Zhang W, Zhang Y, Li Y, Ma D, Zhang H, Kwok LY.
    Nutrients; 2022 Dec 20; 15(1):. PubMed ID: 36615662
    [Abstract] [Full Text] [Related]

  • 24. Lacticaseibacillus rhamnosus Probio-M9 enhanced the antitumor response to anti-PD-1 therapy by modulating intestinal metabolites.
    Gao G, Shen S, Zhang T, Zhang J, Huang S, Sun Z, Zhang H.
    EBioMedicine; 2023 May 20; 91():104533. PubMed ID: 37027929
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic Evaluation of Bifidobacterium animalis subsp. lactis MH-02 as an Adjunctive Treatment in Patients with Reflux Esophagitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Gan L, Wang Y, Huang S, Zheng L, Feng Q, Liu H, Liu P, Zhang K, Chen T, Fang N.
    Nutrients; 2024 Jan 24; 16(3):. PubMed ID: 38337627
    [Abstract] [Full Text] [Related]

  • 26. Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis.
    Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K, Chang H, Fang T, Zhang H.
    mSystems; 2019 Jan 24; 4(2):. PubMed ID: 31020040
    [Abstract] [Full Text] [Related]

  • 27. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
    Chen Y, Shen X, Ma T, Yu X, Kwok LY, Li Y, Sun Z, Li D, Zhang H.
    mSystems; 2023 Feb 23; 8(1):e0130022. PubMed ID: 36688679
    [Abstract] [Full Text] [Related]

  • 28. Administration of two probiotic strains during early childhood does not affect the endogenous gut microbiota composition despite probiotic proliferation.
    Laursen MF, Laursen RP, Larnkjær A, Michaelsen KF, Bahl MI, Licht TR.
    BMC Microbiol; 2017 Aug 17; 17(1):175. PubMed ID: 28818050
    [Abstract] [Full Text] [Related]

  • 29. Lactobacillus rhamnosus Probio-M9 Improves the Quality of Life in Stressed Adults by Gut Microbiota.
    Zheng Y, Yu Z, Zhang W, Sun T.
    Foods; 2021 Oct 08; 10(10):. PubMed ID: 34681433
    [Abstract] [Full Text] [Related]

  • 30. Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial.
    Tian Y, Wu G, Zhao X, Zhang H, Ren M, Song X, Chang H, Jing Z.
    Medicine (Baltimore); 2024 May 24; 103(21):e37883. PubMed ID: 38788020
    [Abstract] [Full Text] [Related]

  • 31. Gut microbiota indole-3-propionic acid mediates neuroprotective effect of probiotic consumption in healthy elderly: A randomized, double-blind, placebo-controlled, multicenter trial and in vitro study.
    Kim CS, Jung S, Hwang GS, Shin DM.
    Clin Nutr; 2023 Jun 24; 42(6):1025-1033. PubMed ID: 37150125
    [Abstract] [Full Text] [Related]

  • 32. Modulation of the gut microbiota by probiotics and symbiotics is associated with changes in serum metabolite profile related to a decrease in inflammation and overall benefits to metabolic health: a double-blind randomized controlled clinical trial in women with obesity.
    Crovesy L, El-Bacha T, Rosado EL.
    Food Funct; 2021 Mar 15; 12(5):2161-2170. PubMed ID: 33565558
    [Abstract] [Full Text] [Related]

  • 33. PHAGE-2 Study: Supplemental Bacteriophages Extend Bifidobacterium animalis subsp. lactis BL04 Benefits on Gut Health and Microbiota in Healthy Adults.
    Grubb DS, Wrigley SD, Freedman KE, Wei Y, Vazquez AR, Trotter RE, Wallace TC, Johnson SA, Weir TL.
    Nutrients; 2020 Aug 17; 12(8):. PubMed ID: 32824480
    [Abstract] [Full Text] [Related]

  • 34. Randomised clinical trial: Bifidobacterium lactis NCC2818 probiotic vs placebo, and impact on gut transit time, symptoms, and gut microbiology in chronic constipation.
    Dimidi E, Zdanaviciene A, Christodoulides S, Taheri S, Louis P, Duncan PI, Emami N, Crabbé R, De Castro CA, McLean P, Bergonzelli GE, Whelan K, Mark Scott S.
    Aliment Pharmacol Ther; 2019 Feb 17; 49(3):251-264. PubMed ID: 30585341
    [Abstract] [Full Text] [Related]

  • 35. Correction to: Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study.
    Mageswary MU, Ang XY, Lee BK, Chung YF, Azhar SNA, Hamid IJA, Bakar MHA, Roslan NS, Liu X, Kang X, Dai L, Sreenivasan S, Taib F, Zhang H, Liong MT.
    Eur J Nutr; 2022 Apr 17; 61(3):1693. PubMed ID: 35122153
    [No Abstract] [Full Text] [Related]

  • 36. Effect of Probiotic Yogurt Supplementation(Bifidobacterium animalis ssp. lactis BB-12) on Gut Microbiota of Female Taekwondo Athletes and Its Relationship with Exercise-Related Psychological Fatigue.
    Zhu J, Zhu Y, Song G.
    Microorganisms; 2023 May 26; 11(6):. PubMed ID: 37374905
    [Abstract] [Full Text] [Related]

  • 37. Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products.
    Zhang Y, Zheng T, Ma D, Shi P, Zhang H, Li J, Sun Z.
    mSystems; 2023 Dec 21; 8(6):e0033123. PubMed ID: 37855616
    [Abstract] [Full Text] [Related]

  • 38. Adjuvant probiotic Bifidobacterium animalis subsp. lactis CP-9 improve phototherapeutic treatment outcomes in neonatal jaundice among full-term newborns: A randomized double-blind clinical study.
    Tsai ML, Lin WY, Chen YT, Lin HY, Ho HH, Kuo YW, Lin JH, Huang YY, Wang HS, Chiu HY, Lin HC.
    Medicine (Baltimore); 2022 Nov 11; 101(45):e31030. PubMed ID: 36397441
    [Abstract] [Full Text] [Related]

  • 39. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
    Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS.
    Clin Nutr; 2017 Feb 11; 36(1):85-92. PubMed ID: 26732026
    [Abstract] [Full Text] [Related]

  • 40. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ, Culpepper T, Nieves C, Ukhanova M, Mai V, Percival SS, Christman MC, Langkamp-Henken B.
    J Am Coll Nutr; 2015 Feb 11; 34(6):459-69. PubMed ID: 25909149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.